Author

Jimmy Savistchenko

Centre National de la Recherche Scientifique

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Ronald MelkiiD· 2 shared Adriano AguzziiD· 1 shared Birgit StierstorferiD· 1 shared Cinzia Tiberi· 1 shared Cynthia Hess KennyiD· 1 shared David WyattiD· 1 shared Dragica Blazevic· 1 shared Frederik H. IgneyiD· 1 shared

Activity by Year

2022-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersSystems Biology

Ronald MelkiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Structure-function relationship of alpha-synuclein fibrillar polymorphs derived from distinct synucleinopathies

Tetiana Serdiuk, Virginie Redeker, Jimmy Savistchenko, Sandesh Neupane, Walther Haenseler, Yanick Fleischmann, Viviane Reber, Sabrina Keller, Cinzia Tiberi, Ruxandra Bachmann-Gagescu, Matthias Gstaiger, Thomas Braun, Roland Riek, Steve Gentleman, Adriano Aguzzi, , Paola Picotti

This study identifies structural and functional differences in alpha-synuclein fibrils from Parkinson's disease, Dementia with Lewy Bodies, and Multiple System Atrophy, linking these differences to disease-specific cellular responses and potential therapeutic targets.

Molecular Systems Biology · Mar 11, 2026Peer-reviewedSystems Biology

AAV-mediated Expression of a Novel Conformational Anti-Aggregated alpha-Synuclein Antibody Prolongs Survival in a Genetic Model of alpha-Synucleinopathies

Matthias J. Duechs, Dragica Blazevic, Philipp Rechtsteiner, Cynthia Hess Kenny, Thorsten Lamla, Sarah Hong Hui Low, Jimmy Savistchenko, Manuela Neumann, Ronald Melki, Tanja Schönberger, Birgit Stierstorfer, David Wyatt, Frederik H. Igney, Thomas Ciossek

This study shows that AAV-mediated delivery of a novel anti-aggregated alpha-synuclein antibody improves survival in a mouse model of alpha-synucleinopathies.

bioRxiv · Nov 30, 2022 · PreprintNeuroscience